These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Addition of 2-nitroimidazole radiosensitizers to cis-diamminedichloroplatinum(II) with radiation and with or without hyperthermia in the murine FSaIIC fibrosarcoma. Herman TS, Teicher BA, Holden SA, Pfeffer MR, Jones SM. Cancer Res; 1990 May 01; 50(9):2734-40. PubMed ID: 2139359 [Abstract] [Full Text] [Related]
4. Combined modality therapy with bleomycin, hyperthermia, and radiation. Teicher BA, Herman TS, Holden SA. Cancer Res; 1988 Nov 15; 48(22):6291-7. PubMed ID: 2460220 [Abstract] [Full Text] [Related]
7. Effect of environmental conditions (pH, oxygenation, and temperature) on misonidazole cytotoxicity and radiosensitization in vitro and in vivo in FSaIIC fibrosarcoma. Holden SA, Teicher BA, Herman TS. Int J Radiat Oncol Biol Phys; 1991 May 15; 20(5):1031-8. PubMed ID: 2022503 [Abstract] [Full Text] [Related]
10. Effect of pH, oxygenation, and temperature on the cytotoxicity and radiosensitization by etanidazole. Teicher BA, Herman TS, Holden SA. Int J Radiat Oncol Biol Phys; 1991 Apr 15; 20(4):723-31. PubMed ID: 1825994 [Abstract] [Full Text] [Related]
11. Schedule dependent tumour growth delay, DNA cross-linking and pharmacokinetic parameters in target tissues with cis-diamminedichloroplatinum(II) and etanidazole with or without hyperthermia or radiation. Teicher BA, Pfeffer MR, Alvarez Sotomayor E, Herman TS. Int J Hyperthermia; 1991 Apr 15; 7(5):773-84. PubMed ID: 1834752 [Abstract] [Full Text] [Related]
12. Sequencing of trimodality therapy [cis-diamminedichloroplatinum(II)/hyperthermia/radiation] as determined by tumor growth delay and tumor cell survival in the FSaIIC fibrosarcoma. Herman TS, Teicher BA. Cancer Res; 1988 May 15; 48(10):2693-7. PubMed ID: 3359430 [Abstract] [Full Text] [Related]
13. Interaction of hyperthermia and radiation in murine cells: hypoxia and acidosis in vitro, tumor subpopulations in vivo. Herman TS, Teicher BA, Holden SA, Collins LS. Cancer Res; 1989 Jun 15; 49(12):3338-43. PubMed ID: 2720686 [Abstract] [Full Text] [Related]
14. Interaction of D,L- and D-tetraplatin with hyperthermia in vitro and in vivo. Epelbaum R, Teicher BA, Holden SA, Ara G, Varshney A, Herman TS. Eur J Cancer; 1992 Jun 15; 28A(4-5):794-800. PubMed ID: 1524897 [Abstract] [Full Text] [Related]
15. Etoposide with lonidamine or pentoxifylline as modulators of alkylating agent activity in vivo. Tanaka J, Teicher BA, Herman TS, Holden SA, Dezube B, Frei E. Int J Cancer; 1991 Jun 19; 48(4):631-7. PubMed ID: 2045206 [Abstract] [Full Text] [Related]
16. Interaction with hyperthermia of tetrachloroplatinum(II)(Nile blue)2 and tetrachloroplatinum(II)(neutral red)2 in EMT6 murine cells and the murine FSaIIC fibrosarcoma. Herman TS, Teicher BA, Pfeffer MR, Khandekar VS, Korbut TT. Cancer Res; 1990 Jul 01; 50(13):3826-31. PubMed ID: 2354434 [Abstract] [Full Text] [Related]
17. Interaction of platinum complexes of thiazin and xanthene dyes with hyperthermia. Herman TS, Teicher BA, Pfeffer MR, Khandekar VS, Alvarez Sotomayor E. Cancer Chemother Pharmacol; 1990 Jul 01; 26(2):127-34. PubMed ID: 2347038 [Abstract] [Full Text] [Related]
18. Minocycline as a modulator of chemotherapy and hyperthermia in vitro and in vivo. Teicher BA, Holden SA, Liu CJ, Ara G, Herman TS. Cancer Lett; 1994 Jul 15; 82(1):17-25. PubMed ID: 8033065 [Abstract] [Full Text] [Related]
19. Interaction of PtCl4(Fast Black)2 with hyperthermia. Teicher BA, Herman TS, Pfeffer MR, Alvarez Sotomayor E, Khandekar VS. Cancer Res; 1989 Nov 15; 49(22):6208-13. PubMed ID: 2804969 [Abstract] [Full Text] [Related]
20. Effect of fluosol-DA/carbogen on etoposide/alkylating agent antitumor activity. Teicher BA, Bernal SD, Holden SA, Cathcart KN. Cancer Chemother Pharmacol; 1988 Nov 15; 21(4):281-5. PubMed ID: 3131032 [Abstract] [Full Text] [Related] Page: [Next] [New Search]